Shailesh Chaturvedi, MD & CEO of Arvind Fashions, discusses the company’s strong performance in the offline channel, weak consumer sentiment during Diwali, margin improvement due to premiumisation, and the company’s strategy for profitable growth to achieve a ROCE target of 20%. He is also confident that margin will sustain at the current level of 53.3% which is a sharp nearly 480 basis point improvement.
Dr Reddy’s, Sun Pharma and other pharma stocks fall up to 3% as Trump threatens 25% tariff on India
Indian pharma stocks fell up to 3% after U.S. President Trump announced a 25% tariff on Indian imports over its trade with Russia. Concerns rose